Literature DB >> 20629073

Neck recurrence after level I-IV or I-III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma.

Mandeep S Bajwa1, Roddy McMillan, Owais Khattak, Mathew Thomas, Ojas P Krishnan, Keith Webster.   

Abstract

BACKGROUND: Controversy remains regarding extending the level I-III selective neck dissection (SND) to include level IV in the management of the clinically N0 (cN0) neck in patients with oral squamous cell carcinoma (OSCC).
METHODS: Histologic and follow-up data of 87 patients with previously untreated OSCC undergoing I-IV SND and 41 undergoing I-III SND between 2002 and 2006 were reviewed.
RESULTS: Of the 98 I-IV SNDs performed, 4 had involvement of level IV. No relationship between tumor variables and level IV involvement was identified. Survival analysis failed to demonstrate a significant difference between I-III and I-IV SND in terms of developing neck recurrence in the 2 years following surgery.
CONCLUSIONS: Level I-III SND is effective management of the cN0 neck (when coupled with postoperative radiotherapy in selected cases) in patients with OSCC, although it is recommended that a larger prospective study be performed in this field.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20629073     DOI: 10.1002/hed.21466

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

Review 1.  Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma.

Authors:  H Hakan Coskun; Jesus E Medina; K Thomas Robbins; Carl E Silver; Primož Strojan; Afshin Teymoortash; Phillip K Pellitteri; Juan P Rodrigo; Sandro J Stoeckli; Ashok R Shaha; Carlos Suárez; Dana M Hartl; Remco de Bree; Robert P Takes; Marc Hamoir; Karen T Pitman; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2014-06-30       Impact factor: 3.147

2.  Transverse cervical vessels as recipient vessels in oral and maxillofacial microsurgical reconstruction after former operations with or without radiotherapy.

Authors:  Zhong-fei Xu; Wei-yi Duan; En-jiao Zhang; Shuang Bai; Yu Tian; Xue-xin Tan; Fa-yu Liu; Chang-fu Sun
Journal:  World J Surg Oncol       Date:  2015-05-14       Impact factor: 2.754

3.  Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma.

Authors:  Ryota Oka; Koh-Ichi Nakashiro; Hiroyuki Goda; Kazuki Iwamoto; Norihiko Tokuzen; Hiroyuki Hamakawa
Journal:  Oncotarget       Date:  2016-01-26

4.  Prognostic impact of the level of neck metastasis in oral cancer patients.

Authors:  Hugo Fontan Köhler; Luiz Paulo Kowalski
Journal:  Braz J Otorhinolaryngol       Date:  2012-12

5.  Predictive factors of occult neck metastasis in patients with oral squamous cell carcinoma.

Authors:  Renato Fortes Bittar; Homero Penha Ferraro; Marcelo Haddad Ribas; Carlos Neutzling Lehn
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.